Edit Goldberg

Mirabel Medical, Inc. develops technology solutions for the detection of breast cancer. Its T-Scan proprietary technology is used for clinical applications such as identification of malignant melanoma. The company has offices in New Jersey and Israel. Mirabel Medical was founded in 1993 and is headquartered in Austin, TX

Incisive Surgical, Inc. engages in the development of mechanical surgical solutions for skin closure. The firm's product INSORB-20 Subcuticular Skin Stapler is a skin closure device designed to combine the cosmetic result of absorbable sutures with the rapid closure times associated with metal skin staplers and eliminate the need to remove metal staples post-operatively. The company founded in 1999 and is headquartered in Trumbull, CT.

McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY.

CooperSurgical, Inc. develops, manufactures, and markets medical instruments. It offers surgical, clinical and practice based, labor and delivery and critical care. The firm’s surgical products include C-section retractors, hysterectomy/laparoscopic instruments and laparoscopic port-site closures. The company was founded in 1990 and is headquartered in Trumbull, CT.

Part of Virtu Financial, Inc., Arbitrade Holdings LLC is a company that markets options on individual equities, equity indices, fixed income instruments, and certain commodities. The company is based in Minnetonka, MN. The company was founded by Ephraim F. Gildor. Arbitrade Holdings was acquired by Knight Capital Group, Inc. on January 12, 2000 for $439.24 million.

Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel.

Convergent Capital SA (CC) is a venture capital investment firm established in 2001 and located west of Paris. CC manages the Convergent Technologies FCPR fund. Their international clientele comprises business angels, entrepreneurs, and institutions including public entities and financial institutions.

Trendlines Medical Misgav (Trendlines) is the venture capital accelerator arm of Trendlines Group Ltd is a Israeli business development and marketing consulting firm founded in 1992, the firm changed their name from Misgav Venture Accelerator in 2013. The firm headquartered in Misgav, Hazafon.

NeuroQuest Ltd. develops biotechnology products. It offers biomarkers and diagnostic kits that use blood tests to detect Alzheimer's and Parkinson's diseases. The company was founded by Eti Yoles, Ishay Attar and Michal Schwartz in 2008 and is headquartered in M.P. Misgav, Israel.

Reapplix A/S specializes in the biological treatment and management of diabetic foot ulcers. It develops the LeucoPatch device, which is composed of precision molded medical grade plastic components, that facilitates a processing of autologous blood. The company was founded by Niels Erik Holm and Rasmus Lundquist in 2008 and is headquartered in Birkerod, Denmark.

Research Instruments Ltd. manufactures micropositioners for the semiconductor industry. Its products include IVF thermometer, pH meter 3, VOC meter, particle counter, RI Pipettes, EZ-Tip, EZ-Grip, EZ-Squeeze, EZ-Strip, Fertisafe Plus, Fertisafe, RI MSC, Integra 3, Saturn 5, RI IMSI, and syringes. The company was founded in 1962 and is headquartered in Falmouth, the United Kingdom.

ProArc Medical Ltd. develops a prostatic device clearing. The firm offers ClearRing product. The company was founded by Yair Feld in August 2010 and is headquartered in Caesarea, Israel.

OCON Medical Ltd. engages in the research and development of intrauterine device. Its products include Intrauterine Ball IUB and IUB SCu300. The company was founded by Ilan Baram on 2008 and is headquartered in Modiin, Israel.

ApiFix Ltd. engages in the development of invasive scoliosis deformity correction systems for adolescent idiopathic scoliosis. The company was founded by Yizhar Floman and Uri Arnin in 2011 and is headquartered in Misgav, Israel.

GestVision, Inc. provides care diagnostic test for preeclampsia. The firm delivers insights for safer pregnancies beginning with a diagnostic for preeclampsia, a poorly understood pregnancy- related condition. It is developing a point of care diagnostic product that provides essential information to OBGYNs for improving patient management and outcomes. The company was founded in 2014 by Wendy L. Davis and is headquartered in Groton, CT.

Gordian Surgical Ltd. engages in the development of port access-closure system. Its product TroClose facilitates closure of abdominal wall during laparoscopic procedures. The company was founded by Zvi Pe’er in 2012 and is headquartered in Misgav, Israel.

Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel.

Endobetix Ltd. develops a nonsurgical implant that mimics the hormonal benefits offered by bariatric surgery. It offers Endobetix Bile Diversion Device which changes the hormonal balance and induces the release of key hormones such as GLP-1 to improve glucose tolerance and reduce fat absorption. The company was founded by Chen Porat, Pierre Sharvit, and Shlomo Lewkowicz in 2012 and is headquartered in Misgav, Israel.

May Health SAS engages in the development of device for the treatment of polycystic ovary syndrome infertility. The company was founded in September 2017 and is headquartered in Paris, France.

Maverick Medical AI Ltd. engages in the development of a artificial intelligence software and machine learning that identifies clinical risk factors out of medical reports such as specialist and hospitalization reports. It focuses on assisting physicians, healthcare providers, and insurers. The company was founded by Yossi Shahak and Eran Feldhay in 2017 and is headquartered in Tel Aviv Israel.

SpliSense Ltd. engages in the development of targeted therapies for genetic diseases based on splicing modulation treating the underlying root cause of the disease. The company was founded on November 10, 2016 and is headquartered in Jerusalem, Israel.

Lauxera Capital Partners SAS is an Independent firm founded in 1992 by Samuel G. Levy. Lauxera Capital Partners SAS is headquartered in Paris.

Renalsense Ltd. is a privately owned Israeli medical device company that specializes in real-time renal diagnostics. The company is based in Jerusalem, Israel. The company's first product, Clarity RMS, provides continuous and automatic monitoring of urine flow for early detection of acute kidney injury (AKI). Renalsense aims to improve critical care management in the ICU and peri-operative setting by providing additional real-time parameters and expanded diagnostic capabilities in their next-generation products. Renalsense was founded in 2009 by Avi Kleiman and Mor Grinstein, and Avi Kleiman has been the CEO since then.

Veranex, Inc. is a tech-enabled service provider that offers a comprehensive platform for the medtech industry. The company is based in Raleigh, NC and has subsidiaries in Sweden, Switzerland, United States, and United Kingdom. The company provides expert guidance for engineering and design, clinical, market access, and regulatory services, enabling accelerated speed to market, controlled development costs, and development risk mitigation. Veranex's holistic approach ensures that all key functional areas are addressed with the highest level of expertise and attention to detail, making it a trusted partner for companies of all sizes. The company was founded in 2021, and Patrick K. Donnelly has been the CEO of the company since 2021.

Intragel Therapeutics Ltd. is an Israeli science-based company that develops an innovative, state-of-the-art treatment for solid tumors based on an intra-tumoral injectable delivery system with extended release of anticancer drugs. The company is based in Nazareth, Israel. The company's technology can be applied to a wide range of anti-cancer drugs and is suitable for various types of solid tumors. Intragel's formula is loaded into a ready-to-use pre-filled syringe, which is applied directly into the tumors. The drug is slowly released, shrinking the tumor without side effects. Intragel was founded by Peter Siman, Avi Domb, and Avner Geva, and Peter Siman has been the CEO since incorporation.